β-Catenin pathway is required for TGF-β1 inhibition of PPARγ expression in cultured hepatic stellate cells

Pharmacological Research

Volumn 66, Issue 3, 2012, Pages 219-225

  Qian, Jingjing ^b   Niu, Minghui ^a   Zhai, Xuguang ^a   Zhou, Qian ^a   Zhou, Yajun ^a  

^a NANTONG MEDICAL COLLEGE   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

Catenin; Hepatic stellate cell; Peroxisome proliferator activated receptor ; Transforming growth factor 1

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; BETA CATENIN; COLLAGEN TYPE 1; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; XAV 939;

ADIPOGENESIS; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RAT; RECEPTOR BLOCKING; STELLATE CELL;

ADIPOGENESIS; ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; COLLAGEN TYPE I; DOWN-REGULATION; GLYCOGEN SYNTHASE KINASE 3; HEPATIC STELLATE CELLS; LIVER CIRRHOSIS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASES; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84864281505     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2012.06.003     Document Type: Article

References (35)

1. H. Tsukamoto Adipogenic phenotype of hepatic stellate cells Alcoholism, Clinical and Experimental Research 29 2005 132S 133S (Pubitemid 43194339)
2. S.R. Farmer Transcriptional control of adipocyte formation Cell Metabolism 4 2006 263 273 (Pubitemid 44430910)
3. M. Lehrke, and M.A. Lazar The many faces of PPARgamma Cell 123 2005 993 999
4. H. She, S. Xiong, S. Hazra, and H. Tsukamoto Adipogenic transcriptional regulation of hepatic stellate cells Journal of Biological Chemistry 280 2005 4959 4967 (Pubitemid 40288671)
5. T. Miyahara, L. Schrum, R. Rippe, S. Xiong, H.F. Yee Jr., and K. Motomura Peroxisome proliferator-activated receptors and hepatic stellate cell activation Journal of Biological Chemistry 275 2000 35715 35722
6. S. Hazra, S. Xiong, J. Wang, R.A. Rippe, V. Krishna, and K. Chatterjee Peroxisome proliferator-activated receptor γ induces a phenotypic switch from activated to quiescent hepatic stellate cells Journal of Biological Chemistry 279 2004 11392 11401 (Pubitemid 38401638)
7. L. Yang, C.C. Chan, O.S. Kwon, S. Liu, J. McGhee, and S.A. Stimpson Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis American Journal of Physiology: Gastrointestinal and Liver Physiology 291 2006 G902 G911
8. N.A. Arango, P.P. Szotek, T.F. Manganaro, E. Oliva, P.K. Donahoe, and J. Teixeira Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium Developmental Biology 288 2005 276 283 (Pubitemid 41713169)
9. C. Christodoulides, C. Lagathu, J.K. Sethi, and A. Vidal-Puig Adipogenesis and WNT signalling Trends in Endocrinology and Metabolism 20 2009 16 24
10. C. Liu, Y. Li, M. Semenov, C. Han, G.H. Baeg, and Y. Tan Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism Cell 108 2002 837 847 (Pubitemid 34327534)
11. J.H. Cheng, H. She, Y.P. Han, J. Wang, S. Xiong, and K. Asahina Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis American Journal of Physiology: Gastrointestinal and Liver Physiology 294 2008 G39 G49
12. R. Bataller, and D.A. Brenner Liver fibrosis Journal of Clinical Investigation 115 2005 209 218 (Pubitemid 40385459)
13. S.L. Friedman Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury Journal of Biological Chemistry 275 2000 2247 2250 (Pubitemid 30081976)
14. Y. Inagaki, and I. Okazaki Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis Gut 56 2007 284 292
15. F. Caraci, E. Gili, M. Calafiore, M. Failla, C. La Rosa, and N. Crimi TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts Pharmacological Research 57 2008 274 282
16. L. Choy, J. Skillington, and R. Derynck Roles of autocrine TGF-β receptor and Smad signaling in adipocyte differentiation Journal of Cell Biology 149 2000 667 681 (Pubitemid 30252400)
17. Y. Zhou, X. Jia, J. Qin, C. Lu, H. Zhu, and X. Li Leptin inhibits PPARgamma gene expression in hepatic stellate cells in the mouse model of liver damage Molecular and Cellular Endocrinology 323 2010 193 200
18. Y. Zhou, X. Jia, G. Wang, X. Wang, and J. Liu PI-3K/AKT and ERK signaling pathways mediate leptin-induced inhibition of PPARgamma gene expression in primary rat hepatic stellate cells Molecular and Cellular Biochemistry 325 2009 131 139
19. T.D. Schmittgen, B.A. Zakrajsek, A.G. Mills, V. Gorn, M.J. Singer, and M.W. Reed Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods Analytical Biochemistry 285 2000 194 204
20. M. Juhaszova, D.B. Zorov, S.H. Kim, S. Pepe, Q. Fu, and K.W. Fishbein Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore Journal of Clinical Investigation 113 2004 1535 1549 (Pubitemid 39071677)
21. Y. Zhou, X. Jia, M. Zhou, and J. Liu Egr-1 is involved in the inhibitory effect of leptin on PPARgamma expression in hepatic stellate cell in vitro Life Sciences 84 2009 544 551
22. K.S. Lee, M. Buck, K. Houglum, and M. Chojkier Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression Journal of Clinical Investigation 96 1995 2461 2468
23. Y. Liu, X.M. Wen, E.L. Lui, S.L. Friedman, W. Cui, and N.P. Ho Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787/ZK22258 Laboratory Investigation 89 2009 1152 1160
24. T. Itagaki, I. Shimizu, X. Cheng, Y. Yuan, A. Oshio, and K. Tamaki Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells Gut 54 2005 1782 1789 (Pubitemid 41697679)
25. T.C. Ho, S.L. Chen, S.C. Shih, J.Y. Wu, W.H. Han, and H.C. Cheng Pigment epithelium-derived factor is an intrinsic antifibrosis factor targeting hepatic stellate cells American Journal of Pathology 177 2010 1798 1811
26. T. Ohyama, K. Sato, K. Kishimoto, Y. Yamazaki, N. Horiguchi, and T. Ichikawa Azelnidipine is a calcium blocker that attenuates liver fibrosis and may increase antioxidant defence British Journal of Pharmacology 165 2012 1173 1187
27. H.A. Baarsma, M.H. Menzen, A.J. Halayko, H. Meurs, H.A. Kerstjens, and R. Gosens β-Catenin signaling is required for TGF-β1-induced extracellular matrix production by airway smooth muscle cells American Journal of Physiology: Lung Cellular and Molecular Physiology 301 2011 L956 L965
28. S. Amini Nik, R.P. Ebrahim, K. Van Dam, J.J. Cassiman, and S. Tejpar TGF-beta modulates beta-catenin stability and signaling in mesenchymal proliferations Experimental Cell Research 313 2007 2887 2895
29. E. Rodionova, M. Conzelmann, E. Maraskovsky, M. Hess, M. Kirsch, and T. Giese GSK-3 mediates differentiation and activation of proinflammatory dendritic cells Blood 109 2007 1584 1592 (Pubitemid 46239592)
30. Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P, Zerr P, et al. Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis. Nature Communications, in press.
31. B. Staels, W. Koenig, A. Habib, R. Merval, M. Lebret, and I.P. Torra Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators Nature 393 1998 790 793 (Pubitemid 28299490)
32. D.S. Straus, and C.K. Glass Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms Trends in Immunology 28 2007 551 558 (Pubitemid 350101420)
33. A.H. Remels, R.C. Langen, H.R. Gosker, A.P. Russell, F. Spaapen, and J.W. Voncken PPARgamma inhibits NF-kappaB-dependent transcriptional activation in skeletal muscle American Journal of Physiology: Endocrinology and Metabolism 297 2009 E174 E183
34. E.A. Jansson, A. Are, G. Greicius, I.C. Kuo, D. Kelly, and V. Arulampalam The Wnt/beta-catenin signaling pathway targets PPARgamma activity in colon cancer cells Proceedings of the National Academy of Sciences of the United States of America 102 2005 1460 1465 (Pubitemid 40209192)
35. K. Gong, D. Xing, P. Li, B. Aksut, N. Ambalavanan, and Q. Yang Hypoxia induces downregulation of PPAR-γ in isolated pulmonary arterial smooth muscle cells and in rat lung via transforming growth factor-β signaling American Journal of Physiology: Lung Cellular and Molecular Physiology 301 2011 L899 L907